| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/22/1997 | US5650425 Anticarcinogenic, antagonist, antitumor agents and antiinflammatory agents |
| 07/22/1997 | US5650416 Piperidinyl thiacyclic derivatives |
| 07/22/1997 | US5650299 Cells producing stem cell proliferation factor |
| 07/22/1997 | US5650152 Vaccines for antitumor agents |
| 07/18/1997 | CA2195371A1 Immunosuppressive-activity potentiating compositions |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025352A1 PROCESS FOR ISOLATING IgG AND IgA |
| 07/17/1997 | WO1997025333A2 Macrocyclic compounds made from suboxide units |
| 07/17/1997 | WO1997025331A1 Heterocycle-condensed morphinoid derivatives (ii) |
| 07/17/1997 | WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 07/17/1997 | WO1997025063A1 Compositions including calcium influx blockers for inhibiting cell growth |
| 07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997024929A1 Human g-protein coupled receptor |
| 07/17/1997 | WO1997009428A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 07/17/1997 | CA2242866A1 Compositions including calcium influx blockers for inhibiting cell growth |
| 07/17/1997 | CA2242778A1 Process for isolating igg and iga |
| 07/17/1997 | CA2242609A1 Heterocycle-condensed morphinoid derivatives (ii) |
| 07/17/1997 | CA2241870A1 Macrocyclic compounds made from suboxide units |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/16/1997 | EP0783894A1 Antibodies modified at two separate sites |
| 07/16/1997 | EP0783893A1 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 07/16/1997 | EP0783886A2 Use of taxol for the manufacture of a medicament for the treatment of cancer |
| 07/16/1997 | EP0783885A2 Use of taxol for the manufacture of a medicament for the treatment of cancer |
| 07/16/1997 | EP0783585A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 07/16/1997 | EP0783573A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 07/16/1997 | EP0783522A1 PEPTIDES FROM THE hPTH SEQUENCE (1-37) |
| 07/16/1997 | EP0783519A1 New peptides with immunomodulatory effects |
| 07/16/1997 | EP0783511A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/16/1997 | EP0783510A1 Human potassium channel 1 and 2 proteins |
| 07/16/1997 | EP0783508A1 The oligosaccharide structure of a ligand for e and p selectin |
| 07/16/1997 | EP0783507A1 Compounds useful as antiproliferative agents and garft inhibitors |
| 07/16/1997 | EP0783505A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 07/16/1997 | EP0783499A1 Benzofuran derivatives as tachykinin antagonists |
| 07/16/1997 | EP0783498A1 Substituted aryl piperazines as neurokinin antagonists |
| 07/16/1997 | EP0783322A1 Peptide compositions capable of down regulating an antigen specific immune response |
| 07/16/1997 | EP0783311A1 Synthetic ganglioside derivatives |
| 07/16/1997 | EP0601154B1 Bpc peptides, their preparation and use |
| 07/16/1997 | CN1154705A Organic compound |
| 07/16/1997 | CN1154699A (Azetidin-1-ylalkyl) lactams as tachykinin antagonists |
| 07/16/1997 | CN1154365A Substituted quinoline-2-carboxylic acid amides, their preparation and their use as medicaments and intermediate products |
| 07/15/1997 | US5648486 Compounds and methods for the treatment of inflammatory and immune disorders |
| 07/15/1997 | US5648467 Human cytokine |
| 07/15/1997 | US5648459 Determined DNA sequences derived from a papillomavirus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions |
| 07/15/1997 | US5648386 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
| 07/15/1997 | US5648373 CoA-IT and PAF inhibitors |
| 07/15/1997 | US5648361 Rapamycin derivatives |
| 07/15/1997 | US5648358 Caffeine and pyrrolidine or piperidine ether antihistamine |
| 07/15/1997 | US5648343 Method for treating LPS-mediated disorders |
| 07/15/1997 | US5648332 Method of treating diabetes mellitus using variable α domain of T-cell receptor |
| 07/15/1997 | US5648072 Methods of inducing gamma interferon and stimulating blood cell populations using natural killer stimulatory factor |
| 07/10/1997 | WO1997024443A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | WO1997024441A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/10/1997 | WO1997024438A1 Immunostimulatory composition and method |
| 07/10/1997 | WO1997024365A1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
| 07/10/1997 | WO1997024350A1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 07/10/1997 | WO1997024139A1 Peanut allergens and methods |
| 07/10/1997 | WO1997024138A2 Medical use of proteases |
| 07/10/1997 | WO1997024137A1 HYBRID WITH INTERFERON-α AND AN IMMUNOGLOBULIN Fc LINKED THROUGH A NON-IMMUNOGENIC PEPTIDE |
| 07/10/1997 | WO1997024117A1 Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl) hydroxamic acid compounds |
| 07/10/1997 | WO1997024116A2 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
| 07/10/1997 | WO1997024112A1 External preparation |
| 07/10/1997 | DE19600301A1 Bioregulatorischer Wirkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung Bioregulatory active substance, process for its preparation and its use |
| 07/10/1997 | CA2241758A1 Methods of treatment with compounds having rar.alpha. receptor specific or selective activity |
| 07/10/1997 | CA2241728A1 Lactone derivatives of 17.beta.-carboxy, carbothio and amide androstane derivatives |
| 07/10/1997 | CA2241373A1 Compositions and methods for t-cell activation comprising gm-csf and tumor antigen fusion proteins |
| 07/10/1997 | CA2241280A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | CA2239522A1 Hybrid with interferon-.alpha. and an immunoglobulin fc linked through a non-immunogenic peptide |
| 07/10/1997 | CA2238885A1 Nucleic acids encoding interferon gamma inducing factor-2 |
| 07/09/1997 | EP0783038A1 Recombinant viral pseudoparticles and their applications as vaccines or as antitumour agents |
| 07/09/1997 | EP0782859A1 Enhancement of the down-regulation of autoimmune diseases by oral administration of autoantigens |
| 07/09/1997 | EP0782627A1 Genetically altered t-cells |
| 07/09/1997 | EP0782615A1 Dna encoding human papillomavirus type 6a |
| 07/09/1997 | EP0782571A1 Compositions and methods for treating mast-cell inflammatory condition |
| 07/09/1997 | EP0782456A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 07/09/1997 | EP0782455A1 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 07/09/1997 | EP0782453A1 Compositions containing tumor rejection antigen precursors or tumor rejection antigens, and an adjuvant and/or growth factor |
| 07/09/1997 | EP0782452A1 Cell growth regulator |
| 07/09/1997 | EP0782444A1 Method of inhibiting conditions associated with bradykinin |
| 07/09/1997 | EP0782441A1 Pharmaceutical control of inflammation |
| 07/09/1997 | EP0720602B1 4-alkylamino-1-phenoxyalkyl piperidines as antiinflammatory, antiallergic and immunomodulating agents |
| 07/09/1997 | EP0663836B1 Treatment of autoimmune and inflammatory disorders |
| 07/09/1997 | CN1154144A Isolated, tyrosinase derived peptides and uses thereof |
| 07/09/1997 | CN1154111A New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 07/08/1997 | US5646148 Piperazinylbenzofuran derivatives |
| 07/08/1997 | US5646138 Prevention of inflammatory or allergic reactions, treatment of cardiovascular or haemodynamic disorders |
| 07/08/1997 | US5646032 Recombinant foamy virus vectors for medicinal, and diagnostic uses, and processes for preparing recombinant foamy virus vectors |
| 07/03/1997 | WO1997023613A2 Cell activation process and reagents therefor |
| 07/03/1997 | WO1997023501A1 Therapeutic compositions |
| 07/03/1997 | WO1997023459A1 Aromatic keto-acids and their derivatives as inhibitors of matrix metalloproteinases |
| 07/03/1997 | WO1997023457A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | WO1997023453A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
| 07/03/1997 | WO1997023243A1 Branched hydrazone linkers |
| 07/03/1997 | WO1997023237A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 07/03/1997 | WO1997023213A1 Process for production of piperidine derivatives |
| 07/03/1997 | WO1997023199A1 Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
| 07/03/1997 | WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases |
| 07/03/1997 | CA2241688A1 Imides as pde iii, pde iv and tnf inhibitors |
| 07/03/1997 | CA2241129A1 Therapeutic compositions |
| 07/03/1997 | CA2241011A1 17-side chain alkynyl-and 20-oxopregna-derivatives of vitamin d, methods for their production and pharmaceutical compositions thereof |
| 07/03/1997 | CA2240834A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |